Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 18, Number 10—October 2012

Letter

Multidrug-Resistant Salmonella enterica, Democratic Republic of the Congo

Marie-France Phoba1, Octavie Lunguya1, Daniel Vita Mayimon, Pantaléon Lewo di Mputu, Sophie Bertrand, Raymond Vanhoof, Jan Verhaegen, Chris Van Geet, Jean-Jacques Muyembe, and Jan JacobsComments to Author 
Author affiliations: National Institute for Biomedical Research, Kinshasa, Democratic Republic of the Congo (M.-F. Phoba, O. Lunguya, J.-J. Muyembe); University Hospital of Kinshasa, Kinshasa (M.-F. Phoba, O. Lunguya, J.-J. Muyembe); Saint-Luc Hospital, Kisantu, Democratic Republic of the Congo (D.V. Mayimona, P. Lewo di Mputu); Institute of Public Health, Brussels, Belgium (S. Bertrand, R. Vanhoof); University Hospital Leuven, Leuven, Belgium (J. Verhaegen, C. Van Geet); and Institute of Tropical Medicine, Antwerp, Belgium (J. Jacobs)

Main Article

Table

MICs and genetic analysis of Salmonella enterica isolates with decreased ciprofloxacin susceptibility, Democratic Rebublic of the Congo

Serotype MIC, mg/L
No. isolates Mutations
Nalidixic acid Ciprofloxacin
Enteritidis 128 0.094 1 Asp82-Asn in gyrA + qnrB
Typhimurium >256 0.125 1 Asp87-Tyr in gyrA + qnrB
Typhi >256 0.19–0.25 7 Ser83-Phe in gyrA

Main Article

1These authors contributed equally to this article.

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO